Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a notoriously difficult cancer to treat. The recent development of immune checkpoint inhibitors has revolutionised HCC therapy; however, successful response is only observed in a small percentage of patients. Biomarkers typically used to predict treatment response i...

Descripción completa

Detalles Bibliográficos
Autores principales: Goggi, Julian L., Ramasamy, Boominathan, Tan, Yun Xuan, Hartimath, Siddesh V., Tang, Jun Rong, Cheng, Peter, Msallam, Rasha, Chacko, Ann-Marie, Hwang, You Yi, Robins, Edward G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328186/
https://www.ncbi.nlm.nih.gov/pubmed/35936114
http://dx.doi.org/10.1155/2021/9305277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328186/
https://www.ncbi.nlm.nih.gov/pubmed/35936114
http://dx.doi.org/10.1155/2021/9305277

Ejemplares similares